ARCHIVES

Cancer Groups Criticize FDA For Ignoring Expert Advice.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

NCI Awards Grants To Physicians For Cancer Detection

August 2, 1991

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977